Europe Synbiotic Products Market

Europe Synbiotic Products Market Size (2024 to 2029)

As per our analysis report, the Europe Synbiotic Products Market is expected to reach USD 282.22 million by 2029 from USD 205.7 million in 2024, growing at a compound annual growth rate (CAGR) of 6.57% during the forecast period.

Synbiotic foods are food products that contain a combination of prebiotics and probiotics in synergy that stimulate the growth and survival of bacteria in the intestine. These bacteria are found mainly in the intestine and colon of a human body in the gastrointestinal tract. Synbiotic is an integral part of functional foods and beverages and are known to improve intestinal functionality, as well as other benefits, including mental, digestive, immune, and heart health enhancements fortification with synbiotic to provide nutritional and health benefits for key market players has spurred market growth.

MARKET DRIVERS AND RESTRAINTS

The demand, in particular, for probiotics and prebiotics in functional foods and beverages is now expected to grow significantly.

The growing health problems of the expanding population have increased the demand for functional foods. Research shows that probiotics work best when combined with prebiotics and the pre-pro combo, meaning two supplements in one dosage form are an effective way to provide additional benefits to product consumers practical and adapted, thus stimulating demand in the European synbiotic products market. The main factors expected to drive growth in the local synbiotic products market are increased consumer awareness of health and the rise of nutritional supplements. In addition, disposable income increases, food consumption patterns change, the demand for prebiotics and probiotics in functional foods and beverages increases, and awareness of the benefits of consuming synbiotic products increase are supposed to fuel development in the synbiotic products business.

The products also come in capsule technology in a Licaps capsule designed for ingredient release during the preferred time, incorporated with a moisture defense system that can help prevent premature activation of a beneficial culture of a probiotic. In addition, frequent innovations in the market accelerate business growth. Moreover, the rising demand for synbiotic products from the animal feed and supplement in food and beverage sectors is further driving the market growth. Nevertheless, high manufacturing cost for synbiotic products is the most challenging element for the market boom.

This research report on the Europe Synbiotic Products market has been segmented and sub-segmented into the following categories.

Europe Synbiotic Products Market By Type

• Dietary Supplements          
• Drinks        
• Sandwiches            
• Dairy and Frozen Desserts
• Bakery And Cake Shop       

By type, the synbiotic products market has been categorized as dietary supplements, drinks, sandwiches, dairy and frozen desserts, bakery and cake shop and others. The dairy segment has the largest share in the European synbiotic products market. However, food supplements are in high consumer demand and are likely to increase during the outlook period.

Europe Synbiotic Products Market By Type Distribution Channel

• Store-based           
• Non-Store based 

The synbiotic products market has been classified by distribution channel as store-based and non-store based. The store-based division is expected to earn a significant portion of market revenue while the non-store segment is presumed to grow faster over the projection period.

Europe Synbiotic Products Market By Application

• Medication             
• Animal Food           
• Food and Beverages   

Europe Synbiotic Products Market By Packaging Material

• Paper        
• Plastic        
• Cup            
• Metal  

By packaging material, the European market is divided into paper, cup, plastic and metal. And depending on the application, the market covers medication, animal food and food and beverages.

Europe Synbiotic Products Market By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

In 2023, the European synbiotic products market gained the largest market share due to increased consumption of functional foods containing fortified nutrients.

The market for Europe synbiotic products has been classified on the basis of geography into United Kingdom, Germany, France, Italy, Spain and the rest of Europe. Europe accounted for the highest share in the global business. It is also foreseen to be the fastest growing regional market in this business in future. Increased consumer awareness of the benefits associated with synbiotic products is the main driver of growth in the European synbiotic products market. Growing intestinal problems among consumers are influencing the demand for synbiotic products in the European nations.

KEY MARKET PLAYERS

Seed Health, Inc, Sabinsa Corporation, Biomin America Inc, Yakult Honsha Co., Ltd, H&H Group, The Kellogg Company, Danone S.A, General Mills, Inc. (US), Pfizer Inc. (US), Daflorn Ltd. (Bulgaria), United Naturals, Probiotical S.p.A. are some of the notable companies in the Europe Synbiotic Products market.

RECENT HAPPENINGS IN THE MARKET

• Behn Meyer Deutschland Holding AG & Co. had the largest share of the synbiotic products market in terms of sales in Europe in 2023.
• In 2019, Sabinsa Corporation launched a synbiotic products -LactoSporin®, which is a new probiotic metabolite for skin and hair.
• In March 2018, a U.S.-based probiotic specialist Viva 5 Corporation entered into a collaboration with NUtech Ventures to become the distributor of a synbiotic products across the globe, which includes a unique human strain of Bifidobacterium adolescentis with a carefully selected galactooligosaccharide (GOS) prebiotic and is Available as a capsule, tablet, stick bar, and powder as a supply, and it can be used as a stand-alone product or in conjecture with other compatible ingredients.
• In December 2010, Synbiotics Corporation was purchased by Pfizer Inc., for a market value of US$ 20 million.